Globus Medical Shares Sold by Covea Finance

Institutional investor reduces stake in medical device company

Mar. 21, 2026 at 8:42am

Got story updates? Submit your updates here. ›

Covea Finance, a French institutional investor, has reduced its stake in Globus Medical, Inc. (NYSE: GMED), a leading medical device company specializing in musculoskeletal solutions for spine and orthopedic applications. The fund sold 41,300 shares, representing a 27.3% decrease in its position during the fourth quarter.

Why it matters

Globus Medical is a prominent player in the medical device industry, known for its innovative spine and orthopedic products. The reduction in Covea Finance's stake could signal a shift in investor sentiment or portfolio rebalancing, which may impact the company's stock performance and market position.

The details

According to a recent filing with the Securities and Exchange Commission, Covea Finance now owns 110,200 shares of Globus Medical, worth approximately $9.6 million at the end of the reporting period. The fund's previous stake in the company was 151,500 shares.

  • Covea Finance reduced its stake in Globus Medical during the fourth quarter of 2025.

The players

Covea Finance

A French institutional investor that has reduced its stake in Globus Medical, Inc.

Globus Medical, Inc.

A leading medical device company specializing in musculoskeletal solutions for spine and orthopedic applications.

Got photos? Submit your photos here. ›

The takeaway

The reduction in Covea Finance's stake in Globus Medical could be a sign of broader market trends or shifts in investor sentiment towards the medical device industry. However, Globus Medical remains a prominent player in the field, and its long-term performance will depend on its ability to continue innovating and meeting the evolving needs of the healthcare market.